Veracyte Officer Files Intent to Sell $234k in Stock via 10b5-1 Plan
VERACYTE, INC.
Subscribe to track VCYT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Veracyte Officer Files Intent to Sell $234k in Stock
Company: VERACYTE, INC. (VCYT) Form: 144 | Filed: 2025-11-05 Significance: Low
Insider: ANN MCGUIRE Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 6,466 • Value: $233,551.92 • Price: ~$36.12/share
Key Insight: This proposed sale is part of a pre-arranged 10b5-1 trading plan adopted in September 2024, indicating it is a planned liquidity event rather than a reaction to recent market news.
Market Context: The transaction represents a negligible fraction (0.008%) of the company's market capitalization and shares outstanding, minimizing any potential market impact.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: VERACYTE, INC. (VCYT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Veracyte has filed a notice of proposed sale for approximately $234k worth of common stock under a pre-scheduled 10b5-1 trading plan.
- Market Impact: The transaction is of low materiality and is not expected to have a meaningful impact on the stock price.
Company Information
| Field | Value |
|---|---|
| Company | VERACYTE, INC. |
| Ticker Symbol | VCYT |
| CIK | 0001384101 |
| Industry | Medical Laboratories |
Insider Information
| Field | Value |
|---|---|
| Name | ANN MCGUIRE |
| CIK | 0001914620 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-05 (Approximate Sale Date) |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 6,466 |
| Price Per Share | ~$36.12 (Calculated) |
| Total Value | $233,551.92 |
| Shares Owned After | Not specified in filing |
| Ownership Type | Not specified in filing |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $233,551.92 |
| % of Market Cap | 0.008% |
| Shares Transacted | 6,466 |
| % of Shares Outstanding | 0.008% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value of $234k is negligible compared to Veracyte's $2.84 billion market capitalization.
- Transaction Significance: The sale represents a very small fraction of the company's total shares outstanding. Such minor transactions by insiders are common for personal financial planning and do not typically signal a change in outlook for the company.
Additional Context
Transaction Notes
- Special Circumstances: This proposed sale is being made pursuant to a Rule 10b5-1 trading plan, which was adopted by the insider on September 4, 2024. This indicates the sale was pre-planned and not based on any immediate, non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.